DOM-MOXIFLOXACIN TABLET
Nchi: Kanada
Lugha: Kiingereza
Chanzo: Health Canada
Tabia za bidhaa
(SPC)
30-12-2016
Hati zingine za bidhaa hii hazipatikani kwa sasa, unaweza kutuma ombi kwa huduma ya wateja wetu na tutakuarifu mara tu tutakapopata.
Tuma ombi.
Tuma ombi.
Viambatanisho vya kazi:
MOXIFLOXACIN (MOXIFLOXACIN HYDROCHLORIDE)
Inapatikana kutoka:
DOMINION PHARMACAL
ATC kanuni:
J01MA14
INN (Jina la Kimataifa):
MOXIFLOXACIN
Kipimo:
400MG
Dawa fomu:
TABLET
Tungo:
MOXIFLOXACIN (MOXIFLOXACIN HYDROCHLORIDE) 400MG
Njia ya uendeshaji:
ORAL
Vitengo katika mfuko:
10/30/100/500
Dawa ya aina:
Prescription
Eneo la matibabu:
QUINOLONES
Bidhaa muhtasari:
Active ingredient group (AIG) number: 0142242001; AHFS:
Idhini hali ya:
CANCELLED PRE MARKET
Idhini ya tarehe:
2019-09-13
Tabia za bidhaa
PRODUCT MONOGRAPH
PR
DOM-MOXIFLOXACIN
Moxifloxacin tablets
400 mg
(as moxifloxacin hydrochloride)
ANTIBACTERIAL AGENT
DOMINION PHARMACAL
DATE OF REVISION:
6111 Royalmount Avenue, Suite 100
December 23, 2016
Montréal, Quebec, Canada
H4P 2T4
SUBMISSION CONTROL NO:
120276
_ _
_Dom-MOXIFLOXACIN Product Monograph _
_Page 2 of 67 _
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
........................................................... 3
SUMMARY
PRODUCT
INFORMATION
...................................................................................
3
INDICATIONS
AND
CLINICAL
USE
.........................................................................................
3
CONTRAINDICATIONS
..............................................................................................................
5
WARNINGS
AND
PRECAUTIONS
.............................................................................................
6
ADVERSE
REACTIONS
............................................................................................................
14
DRUG
INTERACTIONS
.............................................................................................................
18
DOSAGE
AND
ADMINISTRATION
.........................................................................................
21
OVERDOSAGE
...........................................................................................................................
22
ACTION
AND
CLINICAL
PHARMACOLOGY
.......................................................................
23
STORAGE
AND
STABILITY
.....................................................................................................
31
SPECIAL
HANDLING
INSTRUCTIONS
..................................................................................
31
DOSAGE
FORMS,
COMPOSITION
AND
PACKAGING ........................................................ 32
PART II: SCIENTIFIC INFORMATION
..................................................................................
33
PHARMACEUTICAL
INFORMATIO
Soma hati kamili
